Research study Program year 2020 Source: CMS Open Payments

A Phase IV, 12 Week, Randomised, Double Blind Study to Compare Single

Research payments

$4,925,924

300 payments

Through program year 2020, $4,925,924 in research payments was reported against A Phase IV, 12 Week, Randomised, Double Blind Study to Compare Single, across 300 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$49,417	6
2019	Research	$4,876,507	294

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $4,925,924 300 payments

Who received the money Research payments · program years 2019–2020

Abrh LLC Organisation paid for research $874,638 79 payments
Elias Research Associates LLC Organisation paid for research $507,511 22 payments
Clinical Trial Source Organisation paid for research $302,521 18 payments
Florida Premier Research Institute LLC Organisation paid for research $264,066 9 payments
American Health Research Organisation paid for research $249,868 6 payments
Care Research Center INC Organisation paid for research $216,975 8 payments
Clinical Research Of Lancaster Organisation paid for research $215,684 8 payments
Institute Of Healthcare Assessment INC Organisation paid for research $168,144 12 payments
Allianz Research Institute INC Organisation paid for research $161,441 5 payments
Midwest Clinical Research Organisation paid for research $156,825 8 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.